Hochschulschrift
The role of Nrf2 and c-Met for the development of non-alcoholic steatohepatitis (NASH)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
21 cm
- Umfang
-
78 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen
Rheinisch-Westfälische Technische Hochschule Aachen, Dissertation, 2020
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2024, 14:11 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- [2020?]
Ähnliche Objekte (12)
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice
The role of B cells and the gut microbiome in the development of Non-Alcoholic Steatohepatitis (NASH)
Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis
The role of formyl peptide receptor 2 in the development of non-alcoholic steatohepatitis
ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis
Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
The role of formyl peptide receptor 1 in the development of non-alcoholic steatohepatitis
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice
The role of B cells and the gut microbiome in the development of Non-Alcoholic Steatohepatitis (NASH)
Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis
The role of formyl peptide receptor 2 in the development of non-alcoholic steatohepatitis
ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis
Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
The role of formyl peptide receptor 1 in the development of non-alcoholic steatohepatitis
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice
The role of B cells and the gut microbiome in the development of Non-Alcoholic Steatohepatitis (NASH)
Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis
The role of formyl peptide receptor 2 in the development of non-alcoholic steatohepatitis
ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis
Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
The role of formyl peptide receptor 1 in the development of non-alcoholic steatohepatitis